Write your message
Volume 5, Issue 4 (November 2018)                   IJML 2018, 5(4): 288-293 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moinzadeh L, Keramati M R, Jalali M T, Keikhaei B, Saki N, Saki Malehi A, et al . Survey of the Status of Iron and Sclerostin in Major Thalassemia Patients . IJML. 2018; 5 (4) :288-293
URL: http://ijml.ssu.ac.ir/article-1-200-en.html
Cancer Molecular Pathology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:   (1369 Views)
Background and Aims: Thalassemia is one the most prevalent genetic anemia in the world; homozygote patients usually suffer from severe disturbances. Osteopenia and osteoporosis are of various types of thalassemia complications which increase in rate in patients with iron overload conditions. Sclerostin is a protein which enhances bone loss by inhibiting osteoblasts. The aim of this study was to measure sclerostin protein and its association with iron overload in major thalassemia patients.
Materials and Methods: Forty patients with major beta-Thalassemia and 40 healthy control individuals were includedin the study; Sclerostin protein and ferritin were evaluated using enzyme-linked immunosorbent assay method.
Results: Mean sclerostin protein was 100.7 pg/ml, in the case group; it was 143.1 pg/ml in the control group.There was a significant differences between sclerostin protein in case and control groups (p= 0.01). The association of sclerostin and ferritin was not significant in the case group (p= 0.7), while  it was meaningful in the control individuals (p= 0.04).
Conclusions: Our findings suggest that sclerostin protein can play an important role in the pathogenesis of osteoporosis.
Full-Text [PDF 250 kb]   (322 Downloads) |   |   Full-Text (HTML)  (341 Views)  
Type of Study: Research | Subject: Hematology & Blood Banking
Received: 2017/09/21 | Accepted: 2018/09/26 | Published: 2018/11/15

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | International Journal of Medical Laboratory

Designed & Developed by : Yektaweb